United States Pharmaceutical Supply Chain Review Act

United States117th CongressS-1367Senate
Updated: Apr 26, 2021

Summary

United States Pharmaceutical Supply Chain Review Act This bill requires the Federal Trade Commission to submit annually to Congress a report on foreign investment in the U.S. pharmaceutical industry. The report shall address, among other topics, the effect of the industry's reliance on foreign manufacturing.

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

  1. Introduced in Senate

  2. Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.

    Senate

All available records shown.